2026 Clinical Challenges in Hospital Medicine (On-Demand)
-
Register
- Non-member - $800
- Member - $625
- Resident/Fellow - $425
- Student - Free!
2026 Clinical Challenges in Hospital Medicine (On-Demand) is the learning experience for osteopathic internists and subspecialists, residents, and students to cultivate and update their knowledge of hospital medicine and subspecialty care topics.
CME Credit Available:
This activity offers a total of 25.50 1A AOA
Note: ACOI reports credits to the AOA at the beginning of each month.
Release & Review Date:
This activity is valid from July 31, 2026, until July 31, 2029.
NOTE: This package's contents will no longer be available to access after July 31, 2029.
Prices:
Non-Member: $800.00
Member: $625.00
Residents/Fellows: $425.00
Students: FREE
-
Contains 7 Component(s), Includes Credits
CME Credit Available: This activity offers .25 1A AOA Note: ACOI reports credits to the AOA at the beginning of each month. Learning Objectives: In this session, you'll learn how to: • Understand the four components of Osteopathic Continuous Certification (OCC). • Identify subspecialties certified by the American Osteopathic Board of Internal Medicine. • Readily share information with others regarding Osteopathic Continuous Certification (OCC).
CME Credit Available:
This activity offers .25 1A AOA
Note: ACOI reports credits to the AOA at the beginning of each month.
Learning Objectives:
In this session, you'll learn how to:
- Understand the four components of Osteopathic Continuous Certification (OCC).
- Identify subspecialties certified by the American Osteopathic Board of Internal Medicine.
- Readily share information with others regarding Osteopathic Continuous Certification (OCC).
Conflict of Interest Disclosures:
ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.
J. Rico Blanco, MSHA, faculty for this activity, has no relevant relationships with ineligible companies to disclose.
Release & Review Date:
This activity is valid from July 31, 2026, until July 31, 2029.
J. Rico Blanco, MSHA (he/him/his)
Certification Director
American Osteopathic Board of Internal Medicine
J. Rico Blanco has over 20 years of experience in Healthcare Association Management work and holds a Master's in Healthcare Administration. Mr. Blanco has a 360 view of the healthcare industry, having worked in Continuing Medical Education, Graduate Medical Education, and as a residency/fellowship program administrator in roles at the AOA, ACGME, and Advocate Aurora Health.In his personal time, Mr. Blanco is an accomplished fitness instructor and author.
The faculty member, for this activity, has no relevant relationships with ineligible companies to disclose.
-
Contains 6 Component(s), Includes Credits
CME Credit Available: This activity offers .75 1A AOA Note: ACOI reports credits to the AOA at the beginning of each month. Learning Objectives: In this session, you'll learn how to: • Medication Management Is the Most Modifiable Risk Factor, majority of inflammatory arthritis patients are on DMARDs and biologics at time of surgery. Optimizing these agents — especially minimizing glucocorticoids — is the most accessible and impactful preoperative intervention. • Recognize Diagnosis-Specific Complication Patterns AS: pulmonary compromise from chest wall restriction → highest pneumonia risk. PsA: comorbidities and obesity drive adverse events, not disease activity. RA: infection remains the most concerning adverse event. • Implement the Guideline Framework with Nuance ACR guideline recommendations are all conditional — no RCT data exist. Confounding by indication and publication bias limit certainty. Individualized, shared decision-making between rheumatologist, surgeon, and patient is paramount.
CME Credit Available:
This activity offers .75 1A AOA
Note: ACOI reports credits to the AOA at the beginning of each month.
Learning Objectives:
In this session, you'll learn how to:
- Medication Management Is the Most Modifiable Risk Factor, majority of inflammatory arthritis patients are on DMARDs and biologics at time of surgery. Optimizing these agents — especially minimizing glucocorticoids — is the most accessible and impactful preoperative intervention.
- Recognize Diagnosis-Specific Complication Patterns AS: pulmonary compromise from chest wall restriction → highest pneumonia risk. PsA: comorbidities and obesity drive adverse events, not disease activity. RA: infection remains the most concerning adverse event.
- Implement the Guideline Framework with Nuance ACR guideline recommendations are all conditional — no RCT data exist. Confounding by indication and publication bias limit certainty. Individualized, shared decision-making between rheumatologist, surgeon, and patient is paramount.
Conflict of Interest Disclosures:
ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.
Rubaiya Mallay, DO, FACOI, FACR, faculty for this activity, has no relevant relationships with ineligible companies to disclose.
Release & Review Date:
This activity is valid from July 31, 2026, until July 31, 2029.
Rubaiya Mallay, DO, FACOI, FACR (she/her/hers)
Rheumatologist
Suncoast Internal Medicine Consultants
Attending Rheumatologist (SIMC) Suncoast Internal Medicine Consultants
Program Director, Transitional Year /HCA healthcare/USF Morsani College of Medicine, GME
Affiliated with Internal Medicine Residency program and Rheumatology Fellowship HCA healthcare/USF Morsani College of Medicine, at Largo Medical Center
-
Contains 6 Component(s), Includes Credits
CME Credit Available: This activity offers .75 1A AOA Note: ACOI reports credits to the AOA at the beginning of each month. Learning Objectives: In this session, you'll learn how to: • Learn the evolution of immunotherapy drug development and the pathophysiology of immune related adverse events (iRAE) • Understand the timeline of the development of iRAEs with major immunotherapy treatments how how to triage severity. • Perform a comprehensive patient assessment for iRAEs, grading of toxicity and treatment considerations in hospitalized patients.
CME Credit Available:
This activity offers .75 1A AOA
Note: ACOI reports credits to the AOA at the beginning of each month.
Learning Objectives:
In this session, you'll learn how to:
- Learn the evolution of immunotherapy drug development and the pathophysiology of immune related adverse events (iRAE)
- Understand the timeline of the development of iRAEs with major immunotherapy treatments how how to triage severity.
- Perform a comprehensive patient assessment for iRAEs, grading of toxicity and treatment considerations in hospitalized patients.
Conflict of Interest Disclosures:
ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.
Joseph McCollom, DO, faculty for this activity, has no relevant relationships with ineligible companies to disclose.
Release & Review Date:
This activity is valid from July 31, 2026, until July 31, 2029.
Joseph W. McCollom, DO (he/him/his)
Oncologist
Parkview Packnett Family Cancer Institute / Parkview Physicians Group / Parkview Health
Dr. Joseph W. McCollom DO obtained his osteopathic degree from Michigan State University College of Osteopathic Medicine in East Lansing, Michigan. He completed his Internal Medicine residency at Metro Health Hospital in west Michigan and completed a fellowship in Hospice and Palliative Care as well as Hematology/Medical Oncology through Wright State University in Dayton Ohio. His passion is integrating the compassionate care of supportive oncology to the competent innovation of disease directed oncology. Dr McCollom has been able to present at the national and state level as well as several award-winning research presentations locally for integration of supportive care into oncology practice. He is board certified in Internal Medicine, Hospice and Palliative Medicine and Medical Oncology He is an active member of the American College of Osteopathic Internists (ACOI), American Society of Clinical Oncology (ASCO), American Association of Hospice and Palliative Medicine (AAHPM), European Society of Medical Oncology (ESMO). Dr McCollom is sub-specializing in gastrointestinal medical oncology (esophageal, gastric, hepatic, small bowel, pancreatic, colonic, rectal cancer) as well as palliative, integrative and survivorship oncology with a primary clinical research focus in this field. His program achieved an international designation from ESMO as an integrated palliative care in oncology center, one of six centers in the United States. He currently serves as co-chair of the ASCO supported Palliative Care in Oncology Community of Practice, a social media editor for the Oncologist and associate faculty for OncoAlert. He lives in northeast Indiana with his wife and two young children. He enjoys endurance sports and has run several half marathons and a triathlon, is active within his church community and relishes time with his family.
-
Contains 6 Component(s), Includes Credits
CME Credit Available: This activity offers .75 1A AOA Note: ACOI reports credits to the AOA at the beginning of each month. Learning Objectives: In this session, you'll learn how to: • Hypercalcemia in malignancy. • Tumor Lysis Syndrome in malignancy. • Adrenal insufficiency in malignancy Hypoglycemia in malignancy Hyponatremia in malignancy Lactic Acidosis in malignancy.
CME Credit Available:
This activity offers .75 1A AOA
Note: ACOI reports credits to the AOA at the beginning of each month.
Learning Objectives:
In this session, you'll learn how to:
- Hypercalcemia in malignancy.
- Tumor Lysis Syndrome in malignancy.
- Adrenal insufficiency in malignancy Hypoglycemia in malignancy Hyponatremia in malignancy Lactic Acidosis in malignancy.
Conflict of Interest Disclosures:
ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.
Peter Lamie, DO, faculty for this activity, has no relevant relationships with ineligible companies to disclose.
Release & Review Date:
This activity is valid from July 31, 2026, until July 31, 2029.
Peter Lamie, DO
Onco-hospitalist
University of Texas - MD Anderson Cancer Center
Dr. Lamie is a dual board-certified internal medicine physician and Assistant Professor at the University of Texas in Houston, where he practices at the renowned MD Anderson Cancer Center. In his leadership roles, he serves as Medical Director for both Breast Cancer and Sarcoma Cancer Services, overseeing comprehensive clinical programs that provide cutting-edge care to patients. Additionally, he directs a team of 30 Advanced Care Practitioners within the Department of Hospital Medicine, guiding their efforts to deliver high-quality inpatient care and ensuring seamless coordination across multidisciplinary teams.
Dr. Lamie graduated summa cum laude with a Bachelor of Science degree from the University of Missouri–St. Louis. He earned his medical degree from Kansas City University of Medicine and Biosciences and completed his residency at Creighton University. He is board certified by both the American Board of Internal Medicine and the American Osteopathic Board of Internal Medicine.
He is a contributor to a Springer Nature book pending publication, Hematology and Oncology Hospital Medicine: A Guide for the Frontline Clinicians, where he has authored a chapter focused on acute care management of breast cancer. He has contributed to numerous publications and funded research protocols. Dr. Lamie also advises multiple healthcare systems and insurance companies on utilization review and hospitalization guidelines and denials.
As a board member and medical consultant for the HOME institution, he serves as a volunteer providing clinical and spiritual guidance to physicians and patients in underserved regions of Africa and Asia.
-
Contains 6 Component(s), Includes Credits
CME Credit Available: This activity offers .75 1A AOA Note: ACOI reports credits to the AOA at the beginning of each month. Learning Objectives: In this session, you'll learn how to: • Recognize and initiate urgent management of TTP, ITP, and HIT, including key diagnostic features and indications for hematology consultation. Use guideline-based red blood cell and platelet transfusion thresholds in common hospitalized patient scenarios. • Apply evidence-based approaches to the inpatient diagnosis and management of DVT and PE, including anticoagulation selection and risk stratification. • Identify clinical and laboratory findings suggestive of acute leukemia (AML/ALL) and outline appropriate initial inpatient evaluation and stabilization.
CME Credit Available:
This activity offers .75 1A AOA
Note: ACOI reports credits to the AOA at the beginning of each month.
Learning Objectives:
In this session, you'll learn how to:
- Recognize and initiate urgent management of TTP, ITP, and HIT, including key diagnostic features and indications for hematology consultation. Use guideline-based red blood cell and platelet transfusion thresholds in common hospitalized patient scenarios.
- Apply evidence-based approaches to the inpatient diagnosis and management of DVT and PE, including anticoagulation selection and risk stratification.
- Identify clinical and laboratory findings suggestive of acute leukemia (AML/ALL) and outline appropriate initial inpatient evaluation and stabilization.
Conflict of Interest Disclosures:
ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.
Stephanie Haddad, DO, faculty for this activity, has no relevant relationships with ineligible companies to disclose.
Release & Review Date:
This activity is valid from July 31, 2026, until July 31, 2029.
Stephanie A. Haddad, DO (she/her/hers)
Hematology/Oncology Fellow , PGY-5
UT Health San Antonio/Mays Cancer Center
Stephanie A. Haddad, DO; second-year hematology/oncology fellow and current Chief Wellness Fellow at UT Health San Antonio/Mays Cancer Center.She completed her internal medicine residency at Brown University/Kent Hospital. She earned her Bachelor of Arts in Biology with a concentration in Biochemistry from the College of the Holy Cross in Worcester, MA, and completed her medical degree at the West Virginia School of Osteopathic Medicine in Lewisburg, WV.She currently serves as a Review Editor for OncoDaily Medical Journal and participates in the ASCO Mentorship Program. She also contributes as the Osteopathic Medical School Clinical Advisor for the Health Professions Committee at her alma mater, the College of the Holy Cross, and co-chairs the Hem-Onc Fellows Network on Twitter/X.Throughout her career, she has published multiple manuscripts in reputable journals, presented her work in breast oncology at national conferences, and continues to conduct clinical research at her institution. Her work reflects a strong commitment to advancing the field of oncology while mentoring and supporting the next generation of physicians. She is interested in pursuing academic-based clinical practice in medical oncology with a primary focus on breast oncology and clinical research involving clinical trials. -
Contains 6 Component(s), Includes Credits
CME Credit Available: This activity offers .75 1A AOA Note: ACOI reports credits to the AOA at the beginning of each month. Learning Objectives: In this session, you'll learn how to: • Recognize time-sensitive urologic emergencies • Competently initiate patient stabilization • Discern when to consult urology immediately
CME Credit Available:
This activity offers .75 1A AOA
Note: ACOI reports credits to the AOA at the beginning of each month.
Learning Objectives:
In this session, you'll learn how to:
- Recognize time-sensitive urologic emergencies
- Competently initiate patient stabilization
- Discern when to consult urology immediately
Conflict of Interest Disclosures:
ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.
Andrew Hamilton, DO, faculty for this activity, has no relevant relationships with ineligible companies to disclose.
Release & Review Date:
This activity is valid from July 31, 2026, until July 31, 2029.
Andrew J. Hamilton, DO (he/him/his)
Family Medicine Residency Core Faculty
Henry Ford Genesys
Andrew Hamilton, DO, is a core faculty member in the Henry Ford Genesys Family Medicine Residency Program. He is dual board certified in Family Medicine by the American Board of Family Medicine (ABFM) and the American Osteopathic Board of Family Physicians (AOBFP), and additionally board certified in Osteopathic Manipulative Medicine. Dr. Hamilton completed his residency training at Ascension Macomb-Oakland Hospital in Warren, Michigan, after earning his medical degree from Michigan State University College of Osteopathic Medicine in 2018. His professional interests include men’s health and advocacy as well as learner-development within graduate medical education. Outside of his academic and clinical work, Dr. Hamilton enjoys spending time with his wife and three daughters. -
Contains 6 Component(s), Includes Credits
CME Credit Available: This activity offers .75 1A AOA Note: ACOI reports credits to the AOA at the beginning of each month. Learning Objectives: In this session, you'll learn how to: • Identify clinical features, diagnostic strategies, and risk factors associated with the development and progression of atrial fibrillation. • Apply contemporary guideline-directed approaches to anticoagulation, rate control, and rhythm control in patients with atrial fibrillation. • Recognize patient-specific factors that influence treatment selection, including AF burden, comorbid conditions, and indications for early specialty referral.
CME Credit Available:
This activity offers .75 1A AOA
Note: ACOI reports credits to the AOA at the beginning of each month.
Learning Objectives:
In this session, you'll learn how to:
- Identify clinical features, diagnostic strategies, and risk factors associated with the development and progression of atrial fibrillation.
- Apply contemporary guideline-directed approaches to anticoagulation, rate control, and rhythm control in patients with atrial fibrillation.
- Recognize patient-specific factors that influence treatment selection, including AF burden, comorbid conditions, and indications for early specialty referral.
Conflict of Interest Disclosures:
ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.
Chad Link, DO, FACC, FACOI, faculty for this activity, has disclosed the following financial relationships:
• Kiniksa Pharmaceuticals: Consulting Fee - OngoingRelease & Review Date:
This activity is valid from July 31, 2026, until July 31, 2029.
Chad A. Link, DO, FACC, FACOI
Cardiologist
University of Michigan Health- Sparrow
Chad A. Link, D.O. FACC, FACOI received his medical degree from Michigan State University’s College of Osteopathic Medicine in East Lansing, Michigan. He completed both his Internal Medicine Residency and Cardiology Fellowship at Ingham Regional Medical Center in Lansing, Michigan. He is board certified in Internal Medicine, Cardiology and Nuclear Cardiology and serves as the cardiology chairman for the University of Michigan Health System-Sparrow Eaton and Ionia Hospitals and is a clinical assistant professor for the cardiology course at Michigan State University’s College of Osteopathic Medicine.
He specializes in cardiovascular medicine with the University of Michigan Health-Sparrow. Dr. Link’s background includes all aspects of clinical cardiology with specialized interest in the management of coronary artery disease, hyperlipidemia, echocardiography; nuclear cardiology and pulmonary hypertension. Professional memberships include: the American Society of Echocardiography, the American College of Cardiology, and the American Society of Nuclear Cardiology.The faculty member, for this activity, has disclosed the following financial relationships:
- Kiniska-Consulting Fees-Ongoing
-
Contains 6 Component(s), Includes Credits
CME Credit Available: This activity offers .75 1A AOA Note: ACOI reports credits to the AOA at the beginning of each month. Learning Objectives: In this session, you'll learn how to: • Apply 2026 acute ischemic stroke (AIS) updates: prehospital triage, thrombolysis, and thrombectomy selection • Implement 2021 secondary prevention strategies (antithrombotics, lipids, BP, carotids, cardioembolic sources) • Translate 2024 primary prevention guidance into clinic workflows (Life’s Essential 8, sex-specific risk, SDOH)
CME Credit Available:
This activity offers .75 1A AOA
Note: ACOI reports credits to the AOA at the beginning of each month.
Learning Objectives:
In this session, you'll learn how to:
- Apply 2026 acute ischemic stroke (AIS) updates: prehospital triage, thrombolysis, and thrombectomy selection
- Implement 2021 secondary prevention strategies (antithrombotics, lipids, BP, carotids, cardioembolic sources)
- Translate 2024 primary prevention guidance into clinic workflows (Life’s Essential 8, sex-specific risk, SDOH)
Conflict of Interest Disclosures:
ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.
Vikranth Gongidi, DO, FACOI, faculty for this activity, has no relevant relationships with ineligible companies to disclose.
Release & Review Date:
This activity is valid from July 31, 2026, until July 31, 2029.
Vikranth Gongidi, DO, FACOI
Cardiologist
Premier Cardiology of Vero Beach
The faculty member, for this activity, has no relevant relationships with ineligible companies to disclose.
-
Contains 6 Component(s), Includes Credits
CME Credit Available: This activity offers .75 1A AOA Note: ACOI reports credits to the AOA at the beginning of each month. Learning Objectives: In this session, you'll learn how to: • Distinguish cancer-related cachexia from malnutrition as an etiology of weight loss in oncology patients to support appropriate evaluation and patient counseling. • Identify the clinical features, diagnostic criteria, and staging of cachexia in internal medicine patients. • Identify evidence-based management strategies for cancer-related cachexia, including nutritional interventions, pharmacologic therapies, and symptom-directed care.
CME Credit Available:
This activity offers .75 1A AOA
Note: ACOI reports credits to the AOA at the beginning of each month.
Learning Objectives:
In this session, you'll learn how to:
- Distinguish cancer-related cachexia from malnutrition as an etiology of weight loss in oncology patients to support appropriate evaluation and patient counseling.
- Identify the clinical features, diagnostic criteria, and staging of cachexia in internal medicine patients.
- Identify evidence-based management strategies for cancer-related cachexia, including nutritional interventions, pharmacologic therapies, and symptom-directed care.
Conflict of Interest Disclosures:
ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.
Deborah Humphrey, DO, faculty for this activity, has no relevant relationships with ineligible companies to disclose.
Release & Review Date:
This activity is valid from July 31, 2026, until July 31, 2029.
Deborah Humphrey, DO
Associate Professor
University of South Florida/Morsani College of Medicine
Deborah A. Humphrey, DO, FACP, Associate Professor of Internal Medicine, University of South Florida Morsani College of Medicine and Chief, Section of Hospital Medicine, Tampa General Hospital.
Dr. Deborah A. Humphrey is a board-certified internist and hospice and palliative medicine physician with more than three decades of clinical, teaching, and leadership experience. She earned her Doctor of Osteopathic Medicine from Nova Southeastern University and completed internal medicine residency at the University of South Florida (USF), where she served as Chief Resident. At USF she is currently an Associate Professor and serves as a faculty educator for medical students, residents, and fellows.
An academic clinician, Dr. Humphrey has authored and co-authored numerous peer-reviewed publications, invited commentaries, textbook chapters, and case reports in journals including Southern Medical Journal, The Journal of General Internal Medicine, and Case Reports in Medicine. Her scholarly work spans clinical reasoning, hospital medicine, and medical education. She serves as a journal reviewer and regularly presents lectures and abstracts at conference meetings, including the American College of Physicians and the Association of Program Directors in Internal Medicine.
Her excellence in teaching and service has been widely recognized. Honors include the Florida Medical Association Distinguished Physician Award, the USF Distinguished Physicians Alumna Award, the Golden Apple Award for teaching, Fellow of the American College of Physicians, and the Marcus Award for Academic Excellence. She has served as a national judge for the American College of Physicians research and clinical vignette competitions.
Dr. Humphrey contributes to professional advancement through abstract review panels, national competitions, and mentorship programs for osteopathic physicians. Locally, she is committed to community service as Board President of Family Promise of Hillsborough County, a nonprofit supporting homeless families. Through patient care, scholarship, and mentorship, she has dedicated her career to compassionate medicine, education, and improving healthcare delivery.
-
Contains 6 Component(s), Includes Credits
CME Credit Available: This activity offers .75 1A AOA Note: ACOI reports credits to the AOA at the beginning of each month. Learning Objectives: In this session, you'll learn how to: • Explain the physiology of normal sleep and analyze how sleep disruption impacts healing and recovery in hospitalized patients. • Identify and apply appropriate screening tools to detect sleep apnea risk in hospitalized patients. • Formulate evidence-based treatment objectives for managing sleep apnea in hospitalized patients, considering acuity, safety, and continuity of care.
CME Credit Available:
This activity offers .75 1A AOA
Note: ACOI reports credits to the AOA at the beginning of each month.
Learning Objectives:
In this session, you'll learn how to:
- Explain the physiology of normal sleep and analyze how sleep disruption impacts healing and recovery in hospitalized patients.
- Identify and apply appropriate screening tools to detect sleep apnea risk in hospitalized patients.
- Formulate evidence-based treatment objectives for managing sleep apnea in hospitalized patients, considering acuity, safety, and continuity of care.
Conflict of Interest Disclosures:
ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.
Michelle Zetoony Nudell, DO, FACOI, faculty for this activity, has no relevant relationships with ineligible companies to disclose.
Release & Review Date:
This activity is valid from July 31, 2026, until July 31, 2029.
Michelle F. Zetoony-Nudell, DO, FACOI
Clinician and Owner
DO Sleep Solutions, Inc
Board Certified Pulmonary, Sleep and Internal Medicine
Private practice and University Associate Professor NOVA/PCOM/USF
Podcast Cohost Sleep Takeout
Sleep Tampa Bay Organizer
Dr. Michelle Zeotony completed her undergraduate medical education at the Philadelphia College of Osteopathic Medicine. She pursued Internal Medicine (FL) and the subspecialty in Pulmonary and Critical Care Medicine (MI). Following completion of the fellowships she took special interest in sleep disorders and sleep medicine so she completed an additional Fellowship at University of Medicine and Dentistry in NJ. Once she completed training she moved with her family to FL to work in private practice. She has been in private practice since 2011 and now works entirely outpatient to optimize sleep and pulmonary conditions primarily but has a real focus in preventive care and prevention of disability and disease related to medical conditions. Dr. Zetoony speaks locally and nationally on the subjects related to sleep and wellness.The faculty member, for this activity, has no relevant relationships with ineligible companies to disclose.
